Company Description
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia.
The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources.
It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3.
The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents.
The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions.
It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center.
The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014.
The company was incorporated in 1978 and is based in South Easton, Massachusetts.
Country | MA |
Founded | 1978 |
IPO Date | Oct 31, 1996 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 16 |
CEO | Richard T. Schumacher |
Contact Details
Address: 480 Neponset St. Canton, Massachusetts 02021 United States | |
Phone | 5082301828 |
Website | pressurebiosciences.com |
Stock Details
Ticker Symbol | PBIO |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000830656 |
CUSIP Number | 74112E208 |
ISIN Number | US74112E2081 |
Employer ID | 04-2652826 |
SIC Code | 3826 |
Key Executives
Name | Position |
---|---|
Richard T. Schumacher | Founder, President, Chief Executive Officer, Treasurer, Interim Chief Financial Officer, Clerk and Director |
Dr. Edmund Y. Ting Ph.D., Sc.D. Ph.D. | Senior Vice President of Engineering |
Dr. Alexander V. Lazarev Ph.D. | Vice President of Research and Development |
John B. Hollister | Director of Sales and Marketing |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 22, 2024 | 8-K | Current Report |
Apr 1, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
Feb 27, 2024 | DEF 14A | Other definitive proxy statements |
Jan 25, 2024 | 8-K | Current Report |
Nov 20, 2023 | 10-Q | Quarterly Report |
Nov 15, 2023 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
Oct 24, 2023 | 8-K | Current Report |
Aug 21, 2023 | 10-Q | Quarterly Report |
Aug 15, 2023 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
May 15, 2023 | 10-Q | Quarterly Report |